#USA #New York #Meghan Trainor #Motiva Implants #Establishment Labs

Establishment Labs Welcomes Meghan Trainor as Brand Ambassador

In an innovative and groundbreaking move, Establishment Labs® Holdings Inc. (NASDAQ: ESTA) has unveiled its partnership with acclaimed artist Meghan Trainor. This collaboration follows Trainor’s personal choice to undergo breast augmentation using Motiva Implants®, a product known for its safety, incorporation of technology, and aesthetics. With this partnership, the company aims to highlight the significant impact of self-confidence and body positivity in women’s lives.

Meghan Trainor's Personal Journey

The Grammy Award-winning singer shared her transformative experience with breast augmentation, which she pursued after extensive research and reflection. According to Meghan, “Self-confidence and body positivity are so important to me. After losing a significant amount of weight and giving birth to two kids, I struggled with my self-image, particularly regarding my breasts, which were never even.” She explains that the recent FDA approval of Motiva Implants® played a crucial role in her decision to proceed with the surgery, marking a new chapter in her journey towards self-acceptance.

Meghan articulates how she made an informed choice through consultations with multiple plastic surgeons, ultimately selecting Motiva Implants® for their favorable aesthetic results and safety profile. She excitedly commented, “There is just such a difference with these next-gen implants. I'm absolutely in love with the results—they feel so soft and natural.” This renewed confidence has her looking forward to performing again in front of her fans with new outfit choices that reflect her changed figure.

Innovations in Breast Augmentation

Motiva Implants® are celebrated for their innovative design featuring a patented SmoothSilk® surface, scientifically proven to improve biocompatibility and minimize inflammation. This advanced surface technology contributes to a notably low capsular contracture rate of just 0.5%, which is a common complication associated with breast implants. Furthermore, the implants are designed to adapt to the body’s natural movements, maintaining their round shape when lying down and transitioning to a teardrop shape when standing.

Over four million Motiva® devices have been distributed globally since their introduction in 2010. With the rapid adoption among top plastic surgeons in the U.S., the technology is gaining momentum and recognition for its safety and patient satisfaction ratings, which exceed 97%. This marks a significant achievement for women seeking breast augmentation due to its cutting-edge design and proven results.

Voice of the Professionals

Dr. Payman Danielpour, a board-certified plastic surgeon who has implemented Motiva Technology in his practice, expressed enthusiasm about the partnership with Trainor. He noted that the implants fulfill aesthetic goals and prioritize the health and safety of patients. “Motiva is a new generation of implants, and I’m thrilled that Meghan and women all across the U.S. now have access to this advanced technology,” stated Dr. Danielpour.

Conclusion

The partnership between Establishment Labs and Meghan Trainor is a notable milestone, embodying the spirit of empowerment and body positivity for women. As women navigate their choices regarding body aesthetics, this collaboration aims not only to promote a superior product but also to inspire confidence and celebrate individual beauty. The journey of self-discovery and acceptance continues, and with the safety and innovations brought by Motiva Implants®, women can embrace their bodies with newfound pride.

To learn more about Motiva Implants and Meghan Trainor's journey, visit MotivaUSA.com/Meghan.